PM+ partner Content
There's overwhelming evidence supporting a limit on industrially produced ...
Commission's plans for harmonising veterinary medicine authorisation need review, argues IFAH-Europe's ...
Europe's single market is hampered by a lack of harmonisation in cross-border delivery rules, argues Jaap Mulders of the European Express Association.
The EU's new clinical trials regulation still has a few implementation challenges to overcome, says Prof. Christian Dittrich.
Simpler rules for packaging means more veterinary medicines will reach Europe's smaller markets, says IFAH-Europe's...
Montenegro needs to make meaningful reforms if it is to accomplish its goal of EU membership, argues Matthias Menke.
EU digital policy serves as a blueprint for Europe's future economic growth, says Oliver Süme, president of EuroISPA.
MEPs can ensure the right balance between sustainable stocks and a viable fishing sector, says Europêche's Kathryn Stack.
EU’s policymakers need to recognise the scale and threat of Alzheimer’s and Parkinson’s disease, argues Colin Mackay
Current EU veterinary medicines review lacks focus on ROI for innovative companies, argues IFAH-Europe's Rick Clayton.
TTIP will allow Brussels greater influence in Washington, argues Craig Willy.
The EU must ensure that cosmetic ingredients made in Europe are never tested on animals, argues Dr Julia Baines of PETA.
Responsibility and welfare on animal testing go hand in hand, argues Françoise Grossetête.
Cutting the red tape surrounding veterinary medicines will free up resources and bring new innovation, argues Rick Clayton of IFAH-Europe...
Medicated feed is an efficient and practical method of maintaining animal health, explains IFAH-Europe's Roxane Feller.
European innovators need to focus on innovating, they should not be tied down, writes Paolo Falcioni.
High tax rates on spirits in Europe don't always generate their expected revenues, warns Paul Skehan of spiritsEUROPE.
EU is a key partner in the fight against Malaria, but must take greater role, argues Charles Nelson.
Europe's GMO rules are dysfunctional, says Garlich Von Essen.
The veterinary medicines sector is unfairly expected to follow the same procedures as the human sector, argues IFAH-Europe's Roxane Feller.